ReviewInternational journal of molecular sciences2023

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.

Soni Savai Pullamsetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.